- Advertisement -
Subscribe
- Advertisement -

Related

Hedge funds make biotech all the rage

Latest Report

- Advertisement -
HedgeNordic Editorial Team
By HedgeNordic Editorial Team

The search for new investment opportunities has lead the hedge fund industry to assist an investment boom in the biotech sector

The following is according to a story by Financial Times, published on August 2. Equity issuance in

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

HedgeNordic Editorial Team
HedgeNordic Editorial Team
This article was written, or published, by the HedgeNordic editorial team.
Previous article
Spanish hedge funds move closer to factuality
Next article
Asian hedge fund boom prompts Tremont expansion

Latest Articles

Strong Five-Year Run Fuels Excalibur’s Return to SEK 1 Billion AUM

Excalibur Fixed Income has regained the SEK 1 billion mark in assets under management for the first time since 2019, driven by a strong...

Quirky Questions for Dr. Alexander Mende (RPM)

Not every conversation in the hedge fund world needs to revolve around trend signals, Sharpe ratios, or manager due diligence. In HedgeNordic’s ongoing Quirky...

Elementa Tops Swedish Hedge Fund Universe in H1

After celebrating its ten-year anniversary in March, long/short equity fund Elementa closed the first half of 2025 as the best-performing Swedish hedge fund, delivering...

Asgard Winds Down Macro Strategy, Refocuses on Fixed Income

Less than a year after the launch of Asgard-Steno Global Macro Fund – a collaborative effort between macro strategist Andreas Steno Larsen and fixed-income...

Eric Strand’s Green-Gold 60/40 Alternative Roars Back to Life

After a two-and-a-half-year drought, including a rough start to 2025, AuAg Precious Green has taken off in recent months. The fund, Eric Strand’s innovative...

BNY Debuts Tail-Risk Overlay Fund

BNY Investments Newton, the specialist multi-asset and equity management arm of BNY Mellon, has launched the BNY Adaptive Risk Overlay Fund – a tail-hedging...
Load more

Allocator Interviews

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -

Nordic Business Media AB
BOX 7285
SE-103 89 Stockholm, Sweden

Corporate No.: 556838-6170
VAT No.: SE-556838617001

Tel.:+46 (0) 8 5333 8688
Mob.: +46 (0) 7 06566688
E-mail: info@hedgenordic.com

© 2025 Nordic Business Media AB

About Us

Manager Login

Cookie Policy

Privacy Policy

HedgeNordic
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.